Mirum Pharmaceuticals Inc (MIRM) — Cash Flow Reinvestment Rate
Mirum Pharmaceuticals Inc (MIRM) has a Cash Flow Reinvestment Rate of 0.36x as of December 2025, reinvesting $2.21 Million (capex $600.00K plus investments $1.61 Million) from operating cash flow of $6.07 Million. See how much free cash does Mirum Pharmaceuticals Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Mirum Pharmaceuticals Inc Cash Flow Reinvestment Rate (2024–2025)
Historical reinvestment intensity for Mirum Pharmaceuticals Inc across 2 annual periods. For the full cash flow conversion analysis, see MIRM operating cash flow.
Annual Cash Flow Reinvestment Rate for Mirum Pharmaceuticals Inc (2024–2025)
Year-by-year capital reinvestment analysis for Mirum Pharmaceuticals Inc. See Mirum Pharmaceuticals Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.43x | $23.95 Million | $55.83 Million | $954.00K | ▼ -95.1% |
| 2024 | 8.82x | $91.12 Million | $10.32 Million | $993.00K | — |